CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ (11,799,629)	$ 9,363,744
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Transaction cost - derivative liabilities	1,126,070
Change in fair value of derivative warrant liabilities	10,659,080	(16,101,880)
Gain on marketable securities, dividends and interest held in Trust Account	(20,525)	(90,914)
Changes in operating assets and liabilities:
Prepaid expenses	(651,605)	377,371
Accounts payable	961	4,357,744
Accrued expenses	5,560	674,011
Net cash used in operating activities	(680,088)	(1,419,924)
Cash Flows from Investing Activities:
Cash deposited in Trust Account	(414,000,000)
Net cash used in investing activities	(414,000,000)
Cash Flows from Financing Activities:
Repayment of note payable to related parties	(130,492)
Proceeds received from initial public offering, gross	414,000,000
Offering costs paid	(8,619,770)
Proceeds received from private placement	11,080,000
Proceeds from issuance of ordinary shares to initial shareholders	25,000
Net cash provided by financing activities	416,354,738
Net change in cash	1,674,650	(1,419,924)
Cash - beginning of the period	0	1,674,650
Cash - end of the period	1,674,650	$ 254,726
Supplemental disclosure of noncash financing activities:
Deferred underwriting commissions charged to additional paid-in capital in connection with initial public offering	14,490,000
Offering costs included in accrued expenses	410,000
Offering costs charged to additional paid-in capital in connection with the initial public offering	$ 880,262